Return to homepagePandemic Pact

to evaluate different COVID vaccine platforms in the lymphoid follicle system in order to better understand how this in vitro system might be used to inform future selections of vaccine platforms for other vaccine antigens

Grant number: INV-002274

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022

  • Known Financial Commitments (USD)

    $852,419

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    Harvard University

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine design and administration

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform.

DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseases.